Ontology highlight
ABSTRACT:
SUBMITTER: Glastras SJ
PROVIDER: S-EPMC7230791 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
Glastras Sarah J SJ Cohen Neale N Dover Thomas T Kilov Gary G MacIsaac Richard J RJ McGill Margaret M Fulcher Greg R GR
Journal of clinical medicine 20200411 4
Treatment intensification in people with type 2 diabetes following failure of basal insulin commonly involves the addition of a rapid-acting insulin analogue (basal plus one or more prandial doses; multiple daily injections) or by a switch to premixed insulin. Insulin degludec/insulin aspart (IDegAsp), comprising rapid-acting insulin aspart and ultra-long-acting insulin degludec in solution, enables both fasting and post-prandial glucose control, with some advantages over other treatment intensi ...[more]